China Plans To Revise Drug Administration Law To Facilitate Industry Consolidation
This article was originally published in PharmAsia News
Executive Summary
China plans to revise its drug administration law to facilitate industry consolidation, RDPAC’s managing director said in a recent interview in Shanghai.